[Concept for routine practice data collection for valoctocogene roxaparvovec acc. to the Law for More Safety in the Supply of Medicines (GSAV): Evaluation of the study protocol (Version 1.0) and the statistical analysis plan (Version1.0) – Second addendum to Commission A22-20]

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018005258
Original Title: Anwendungsbegleitende Datenerhebung zu Valoctocogen Roxaparvovec: Prüfung des Studienprotokolls (Version 1.0) und des statistischen Analyseplans (Version 1.0) - 2. Addendum zum Projekt A22-20
Project Status: Completed
Year Published: 2023
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Hemophilia A
  • Antibodies, Bispecific
  • Factor VIII
  • Genetic Therapy
  • Valoctocogene Roxaparvovec
  • Hemophilia A
  • Benefit Assessment
  • Registries
  • Research Design
  • Peer Review – Research
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.